by The global kidney stone management market size reached USD 2.73 billion in 2023 and is projected to attain around USD 4.65 billion by 2033, growing at a CAGR of 5.47% from 2024 to 2033.
Key Points
- North America dominated the kidney stone management market globally in the previous year of 2023, and it is poised to hold its position during the forecast period.
- Asia Pacific is an expanding market and is projected to hold a significant market share in 2023.
- Based on stone type, the calcium oxalate segment held the largest share in the market in 2023.
- Based on diagnostics, the ultrasound segment held a significant share of the market in 2023.
- Based on treatment, the extracorporeal shock wave lithotripsy- ESWL segment held the largest share in 2023 and dominated the kidney stone management market globally
- Based on end use, the hospitals segment held the largest market share and dominated the market.
- Based on end use, the specialty clinics segment is expected to experience the highest growth rate over the forecast period.
The kidney stone management market encompasses a range of medical devices, medications, and procedures aimed at treating and preventing kidney stones. Kidney stones, also known as renal calculi, are solid masses made up of crystals that form in the kidneys when there is an imbalance in the urine’s composition. These stones can cause severe pain and discomfort, leading to complications such as urinary tract infections and kidney damage if left untreated. The market for kidney stone management is driven by the increasing prevalence of kidney stones globally, coupled with advancements in medical technology and growing awareness about kidney stone prevention and treatment options.
Get a Sample: https://www.precedenceresearch.com/sample/3941
Growth Factors
Several factors contribute to the growth of the kidney stone management market. One significant factor is the rising incidence of kidney stones worldwide, attributed to factors such as dietary habits, sedentary lifestyles, and dehydration. Additionally, technological advancements in imaging techniques, such as ultrasound and computed tomography (CT) scans, have improved the diagnosis and treatment planning for kidney stones, driving market growth. Moreover, the growing adoption of minimally invasive procedures, such as extracorporeal shock wave lithotripsy (ESWL) and ureteroscopy, has led to shorter recovery times and reduced hospital stays, further boosting market expansion.
Region Insights:
The kidney stone management market exhibits regional variations influenced by factors such as healthcare infrastructure, prevalence of kidney stones, and regulatory environments. North America and Europe dominate the market due to the high prevalence of kidney stones in these regions and the presence of well-established healthcare systems. In Asia Pacific, the market is witnessing rapid growth driven by increasing healthcare expenditure, rising awareness about kidney stone management, and advancements in medical technology. Emerging economies in Latin America and the Middle East & Africa are also experiencing growth as healthcare infrastructure improves and access to medical services expands.
Kidney Stone Management Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 5.47% |
| Global Market Size in 2023 | USD 2.73 Billion |
| Global Market Size by 2033 | USD 4.65 Billion |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Type of Stone, By Diagnostics Method, By Treatment, and By End-use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Kidney Stone Management Market Dynamics
Drivers:
Several drivers propel the kidney stone management market forward. One key driver is the increasing adoption of minimally invasive procedures, which offer advantages such as reduced recovery time, shorter hospital stays, and lower risk of complications compared to traditional open surgeries. Additionally, the growing prevalence of risk factors such as obesity, diabetes, and hypertension contributes to the rising incidence of kidney stones, driving demand for management and treatment solutions. Furthermore, advancements in medical technology, such as laser lithotripsy and robotic-assisted surgeries, enhance the efficacy and safety of kidney stone management procedures, fueling market growth.
Opportunities:
The kidney stone management market presents numerous opportunities for growth and innovation. Expansion into emerging markets offers significant growth potential, as these regions witness increasing healthcare spending and demand for advanced medical services. Moreover, investments in research and development to develop novel treatment modalities and preventive measures for kidney stones present lucrative opportunities for market players. Additionally, partnerships and collaborations between healthcare organizations, research institutions, and industry players can facilitate the development of innovative solutions and enhance market penetration.
Challenges:
Despite the growth prospects, the kidney stone management market faces several challenges. Access to healthcare services remains a concern in some regions, particularly in rural and underserved areas, limiting the adoption of advanced treatment options. Additionally, the high cost associated with kidney stone management procedures and medications may pose challenges, especially in developing countries with limited healthcare budgets. Moreover, regulatory hurdles and reimbursement issues can impede market growth by delaying the approval and adoption of new technologies and treatments. Furthermore, patient compliance with preventive measures such as dietary modifications and hydration remains a challenge, impacting the effectiveness of kidney stone management strategies. Addressing these challenges requires collaboration between healthcare stakeholders to improve access to care, reduce costs, and enhance patient education and adherence to treatment regimens.
Read Also: Facial Skincare Market Size to Rake USD 169.57 Billion by 2033
Recent Developments
- In June 2022, Olympus, a technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced the launch of the SoltiveTM SuperPulsed Laser System.
- In June 2022, Dornier MedTech and Endoluxe signed a multi-year exclusive distribution contract. Dornier and Endoluxe provide products and systems targeted toward the urology market, offering innovation and value.
Kidney Stone Management Market Companies
- Cook Medical Inc. (US)
- Boston Scientific Corporation (U.S.)
- Olympus Corp. (Japan)
- C.R. Bard Inc. (U.S.)
- Storz Medical AG (Switzerland)
- Richard Wolf GmbH (Germany)
- Lumenis (Israel)
- EDAP TMS (France)
- DirexGroup (Germany)
- Elmed Electronics & Medical Industry & Trade Inc. (Turkey)
- Medi spec Ltd. (U.S.)
- Convergent Laser Technologies (U.S.)
- E.M.S. Electro Medical Systems S.A. (Switzerland)
- Dornier MedTech GmbH (Germany)
- Stryker Corp. (U.S.)
- Olympus Corp. (Japan)
Segments Covered in the Report
By Type of Stone
- Calcium oxalate
- Calcium phosphate
- Uric acid
- Cysteine
- struvite
By Diagnostics Method
- Abdominal X-Ray
- Computed Tomography
- Ultrasound
- Abdominal MRI
- Intravenous Pyelography
- Others
By Treatment
- Extracorporeal Shock Wave Lithotripsy ESWL
- Ureteroscopy
- Percutaneous Nephrolithotomy PCNL
- Others
By End-use
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centres
- Other
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
